Scientists have found that lupus symptoms improve with age as immune system genes become less active, offering new insight into age-related treatment strategies.
Prof. Hartmut J. Ehrlich, MD, CEO of Abivax, explains why the Company’s drug candidate, obefazimod, has the potential to treat Inflammatory Bowel Diseases.
The Invisible Extinction explores the burgeoning new science of fecal microbiota transplants and how it can help those suffering from chronic illnesses.
Dr Joana Torres, Gastroenterologist, Expert in Clinical IBD and UEG* Rising Star Awardee, highlights the most challenging aspects of living with inflammatory bowel disease and the unmet medical needs in IBD management.
Christen Richards, Committee Member from MS Society Jersey, unpacks multiple sclerosis symptoms for us, focusing on recognising the key points to help the diagnostic process.
Vitamin D deficiency is linked to chronic inflammation, which can contribute to a wide range of complex diseases including type 2 diabetes, heart disease, and autoimmune diseases.
Researchers find that moderate calorie restrictions – with no specific diet – can shift the immuno-metabolic state in a way which can be protective of human health.
Through a McMaster University led study, new evidence showing a correlation between psychological stress and Crohn’s disease flare-ups has been identified.
Sarah Woolnough, CEO of Asthma UK and the British Lung Foundation, reflects on landmark research undertaken by the charity ahead of World COPD Day, including the largest ever survey of people with COPD in the UK.
Dr Eugene Durenard, CEO of Hyperbolic Holdings GmbH discusses promising emerging technologies in the field of early detection and prevention of major chronic diseases.
Leading digestive health experts and MEP Sarah Wiener address how healthy nutrition, starting from a young age, can help to reduce the risk of chronic digestive diseases and improve the health of our gut microbiome.
Dr Juliana Bowles, School of Computer Science, University of St Andrews, discusses how to tackle polypharmacy and multimorbidities with computational techniques.
![Figure 1 - The figure illustrates the diversity and multi-scale nature of the structures in the Galaxy. The first two lines are real astronomical images, which go from the galactic disk itself and down to the planet-forming disks. The last two lines are generated from numerical simulations and aim to understand and interpret the observations. [adapted from Facchini et al. 2025, Göller et al. 2025, Hennebelle et al. 2022, Lebreuilly et al. 2024, Molinari et al. 2016, 2025, Reissl et al. 2016]](https://www.openaccessgovernment.org/wp-content/uploads/2025/08/figure.png)
